Racial disparities in breast cancer outcome: Insights into host-tumor interactions

Cancer

Volumn 110, Issue 9, 2007, Pages 1880-1888

  Demicheli, Romano ^a   Retsky, Michael W ^b   Hrushesky, William J M ^c   Baum, Michael ^d   Gukas, Isaac D ^e   Jatoi, Ismail ^f  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

African American; Breast cancer; Caucasian American; Host tumor interaction; Racial traits

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ADJUVANT THERAPY; ADULT; AFRICAN AMERICAN; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST TUMOR; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CAUCASIAN; COMBINATION CHEMOTHERAPY; DISEASE COURSE; FEMALE; HOST TUMOR INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NONHUMAN; ONSET AGE; OUTCOMES RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; SOCIOECONOMICS;

AFRICAN AMERICANS; ANIMALS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MODELS, BIOLOGICAL; RISK FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 35648937620     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22998     Document Type: Review

References (66)

1. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94:471-473.
2. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
3. Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 2005;23:7836-7841.
4. Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol. 2006;24:2170-2178.
5. Wojcik BE, Spinks MK, Stein CR. Effects of screening mammography on the comparative survival rates of African American, white, and Hispanic beneficiaries of a comprehensive health care system. Breast J. 2003;9:175-183.
6. Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare System. Cancer. 2003;98:894-899.
7. Lilienfeld AM, Johnson EA. The age distribution in female breast and genital cancers. Cancer. 1955;8:875-882.
8. Easton D. Breast cancer - not just whether but when? Nat Genet. 2000;26:390-391.
9. Bernards R, Weinberg RA. Metastasis genes: a progression puzzle. Nature. 2002;418:823.
10. Hellman S, Harris JR. Natural history of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:407-423.
11. Armitage P, Doll R. A 2-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957;11:161-169.
12. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954;8:1-12.
13. Brinton LA, Lacey J, Devesa SS. Epidemiology of breast cancer. In: Donegan WL, Spratt JS, editors. Cancer of the Breast. 5th ed. Philadelphia: Saunders; 2002:111-132.
14. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15:17-35.
15. Clemmesen J. Carcinoma of the breast. Br J Radiol. 1948;21:583-590.
16. Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004;83:77-86.
17. Anderson WF, Matsuno RK. Breast cancer heterogeneity: a mixture of at least 2 main types. J Natl Cancer Inst. 2006;98:948-951.
18. Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat. 2002;76:27-36.
19. Anderson WF. Puberty and genetic susceptibility to breast cancer. N Engl J Med. 2003;349:1088-1089.
20. De Waard F, Baanders-van Halewijn EA, Huizinga J. The bimodal age distribution of patients with mammary carcinoma; evidence for the existence of 2 types of human breast cancer. Cancer. 1963;17:141-151.
21. Anderson WF, Jatoi I, Devesa SS. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat. 2005;90:127-137.
22. Cox B. Variation in the effectiveness of breast screening by year of follow-up. J Natl Cancer Inst Monogr. 1997;22:69-72.
23. Retsky M, Demicheli R, Hrushesky W. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat. 2001;65:217-224.
24. Demicheli R, Bonadonna G, Hrushesky WJM, Retsky MW, Valagussa P. Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. J Clin Oncol. 2004;22:102-107.
25. Baum M, Demicheli R, Hrushesky W, Retsky M. Does surgery unfavorably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005;41:508-515.
26. Gukas ID. Does surgery induce angiogenesis in breast cancer? Supporting evidence from Africa. Int J Surg. 2005;3:289.
27. Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003;139:558-563.
28. Demicheli R, Bonadonna G, Hrushesky WJM, Retsky MW, Valagussa P. Menopausal status dependence of the timing of breast cancer recurrence following primary tumour surgical removal. Breast Cancer Res. 2004;6:R689-696.
29. Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G. Local recurrences following mastectomy: support for the concept of tumour dormancy. J Natl Cancer Inst. 1994;86:45-48.
30. Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumour dormancy. Breast Cancer Res Treat. 1996;41:177-185.
31. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency. Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153:865-873.
32. Naumov GN, MacDonald IC, Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 2002;62:2162-2168.
33. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
34. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-153.
35. Guba M, Cernaianu G, Koehl G, et al. A primary tumour promotes dormancy of solitary tumour cells before inhibiting angiogenesis. Cancer Res. 2001;61:5575-5579.
36. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
37. Simpson-Herren L, Sanford AH, Holmquist JP. Effects of surgery on the cell kinetics of residual tumour. Cancer Treat Rep. 1976;60:1749-1760.
38. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumour. Cancer Res. 1982;39:3861-3865.
39. Demicheli R, Retsky MW, Swartzendruber DE, Bonadonna G. Proposal for a new model of breast cancer metastatic development. Ann Oncol. 1997;8:1075-1080.
40. Retsky MW, Demicheli R, Swartzendruber DE, et al. Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat. 1997;45:193-202.
41. Demicheli R, Miceli R, Moliterni A, et al. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumour dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005;16:1449-1457.
42. Demicheli R, Valagussa P, Bonadonna G. Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy. Breast Cancer Res Treat. 2002;75:127-134.
43. Retsky M, Demicheli R, Hrushesky WJM. Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. Int J Surg. 2005;3:179-187.
44. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature. 2000;406:747-752.
45. Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, Schmeichel KL. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 1999;59:1757-1763.
46. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci. 2004;117:1495-1502.
47. McDaniel SM, Rumer KK, Biroc SL, et al. Remodelling of the mammary microenvironment after lactation promotes breast tumour cell metastasis. Am J Pathol. 2006;168:608-620.
48. Cooper AP. In: Lee A, editor. Practice and Principles of Surgery. London: E. Cox; 1836.
49. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet. 1896;11:104-107.
50. Hrushesky WJM. Commentary: rhythmic menstrual cycle modulation of breast cancer biology. J Surg Oncol. 2000;74:238-241.
51. Anderson T. Mitotic activity in breast. J Obstet Gynecol. 1984;4:S114-S118.
52. Wood PA, Bove K, You S, Chambers A, Hrushesky WJM. Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther. 2005;4:1065-1075.
53. Wood PA, Hrushesky WJM. Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005;91:95-102.
54. Manson JM, Sammel MD, Freeman EW, Grisso JA. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril. 2001;75:297-304.
55. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hnkinson SE. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev. 2005;14:2147-2153.
56. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics. 1997;99:505-512.
57. Kato I, Toniolo P, Koenig KL, et al. Epidemiologic correlates with menstrual cycle length in middle aged women. Eur J Epidemiol. 1999;15:809-814.
58. Hrushesky WJ, Bluming AZ, Gruber SA. Menstrual influence on surgical cure of breast cancer [letter]. Lancet. 1990;335:984.
59. Hrushesky WJM. Breast cancer, timing of surgery, and the menstrual cycle: call for prospective trial. J Women's Health. 1996;5:555-565.
60. Love RR, Duc NB, Dinh NV, et al. Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer. J Natl Cancer Inst. 2002;94:662-669.
61. Sorlie T, Wang Y, Xiao C, et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across 3 different platforms. BMC Genomics. 2006;7:127.
62. Gasparini G, Dal Fior S, Pozza F, Bevilacqua P. Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast Cancer Res Treat. 1989;14:329-336.
63. Demicheli R, Bonadonna G, Greco M, et al. Comment to Anderson WF, Jatoi I, Devesa SS: Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat. 2005;90:127-137.
64. Breast Cancer Res Treat. 2006;97:341-343 (Comment).
65. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869-10874.
66. Sotiriou C, Neo S-Y, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003;100:10393-10398.